GPNX
NOTIFICATION PROCESSED BY IB
06/25/2026
Back to search
Official data from USPTO
EGZOVA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
06/25/2026
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
02/13/2024
Registration date
12/17/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/17/2024
Last transaction
06/25/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
JP
Examiner
SEVERSON, JUSTIN
Law office
M20
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
TAIHO PHARMACEUTICAL CO., LTD.
Representatives
IWASE Hitomi
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical purposes in the field of oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations
Publications
History of USPTO decisions and trademark events.
16 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
05/04/2026
XXCR
GENERIC MADRID TRANSACTION CREATED
05/04/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
10/03/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/17/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
09/17/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/16/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
12/17/2024
PUBO
PUBLISHED FOR OPPOSITION
10/15/2024
NPUB
NOTICE OF PUBLICATION
09/25/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/11/2024
DOCK
ASSIGNED TO EXAMINER
09/05/2024
MAFR
APPLICATION FILING RECEIPT MAILED
05/07/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/02/2024
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
04/26/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/18/2024
Continuous trademark protection
Get notified about every new filing that threatens EGZOVA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.